A detailed history of Shell Asset Management CO transactions in Arvinas, Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 5,988 shares of ARVN stock, worth $154,849. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,988
Previous 6,117 2.11%
Holding current value
$154,849
Previous $163,000 9.82%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$23.66 - $32.73 $3,052 - $4,222
-129 Reduced 2.11%
5,988 $147,000
Q1 2024

Jul 31, 2024

SELL
$36.38 - $52.31 $14,006 - $20,139
-385 Reduced 5.92%
6,117 $163,000
Q1 2024

May 14, 2024

SELL
$36.38 - $52.31 $8,403 - $12,083
-231 Reduced 3.43%
6,502 $268,000
Q4 2023

Feb 14, 2024

BUY
$14.19 - $42.33 $95,541 - $285,007
6,733 New
6,733 $277,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.38B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.